“What this paper illustrates is the incredible power of biocatalysis to manufacture incredibly complex macrocyclic peptides,” says David A. Thaisrivongs, who leads the biocatalysis team in Merck & Co.

This Collection supports and amplifies research related to SDG 12 - Responsible Consumption & Production. Microbial biocatalysis refers to the use of microorganisms or their enzymes to catalyze ...

Quantum Genesis AI Corp. (OTC: QGAI) (the "Company"), a biotechnology company focused on enzyme engineering, molecular modeling, and biocatalysis technologies, is issuing this statement to clarify ...

Merck researchers developed a highly sustainable way to synthesize the macrocyclic peptide drug enlicitide, increasing ...

Public Policy/Govt Quantum Genesis AI Issues Clarification Regarding Research Activities and Intellectual Property 19.05.2026 / 21:11 CET/CEST The issuer is solely responsible for the content of this ...

SAN DIEGO, CA, UNITED STATES, May 20, 2026 /EINPresswire.com/ -- Key Takeaways 1.WuXi AppTec's integrated CRDMO ...

Codexis outlined ongoing commercial discussions supported by a "very, very healthy" sales funnel spanning large pharma, ...

Research and Development expenses for the first quarter of 2026 were $11.4 million compared to $12.9 million in the first quarter of 2025. The decrease was primarily due to lower allocable costs, ...

Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.

Round led by PXN Ventures, with additional funding from existing investors IQ Capital and Northern Gritstone * Company uses quantum physics, AI m ...